fashion -WSS

fashion

author：knowledge 2025-10-01 12:00:35 Page View：718

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Creating egg and sperm cells from stem cells raises ethical issues
Next article： After affirmative action ruling, medical educators look to 'holistic review'

comprehensive

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Virtual Event: March of the Biosimilars

Editor’snote:Arecordingoftheeventisembeddedbelow.SeveralbiosimilarversionsofHumira,whichforyearshasb

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

Long Covid research funding gets a major boost from NIH

NIHgaveaprojecttostudyandfindtreatmentsforlongCovidmoremoneythisweek.AdobeWASHINGTON—TheBidenadminis

fashion

explore

comprehensive

Long Covid research funding gets a major boost from NIH